Glutamate dehydrogenase (GDH; EC 1.4.1.2 / 1.4.1.3 / 1.4.1.4) is a key oxidoreductase widely distributed in bacteria, fungi, plants, and animals. It catalyzes the reversible interconversion between L-glutamate and α-ketoglutarate (α-KG), coupled with the production or assimilation of ammonia and tightly linked to the NAD⁺/NADH or NADP⁺/NADPH cofactor systems. As a key node linking amino acid metabolism, the tricarboxylic acid (TCA) cycle, and nitrogen metabolism, GDH has important biological and applied value in hepatic ammonia production and substrate supply for the urea cycle, ammonia buffering in the brain, tumor glutamine metabolism, as well as in industrial fermentation and biochemical analytical assays.
I. Molecular Structure and Classification of Glutamate Dehydrogenase
1.1 Structural Features
(1) GDH generally exists as an oligomer, with the number of subunits varying between species. Most bacterial and some fungal GDHs are hexamers. Mammalian liver mitochondrial GDH is commonly found as a hexamer that can be viewed functionally as two associated trimers, with a total molecular weight of approximately 280–320 kDa. Each subunit has a molecular mass of about 50 kDa and is composed of several conserved domains, including a catalytic domain responsible for substrate turnover and regulatory domains involved in cofactor binding and allosteric control.
(2) Within a single subunit, substrate-binding and cofactor-binding regions can generally be distinguished. The catalytic domain contains conserved residues (such as lysine, histidine, aspartate, etc.) that participate in the recognition and chemical transformation of glutamate and α-ketoglutarate. The cofactor-binding domain often adopts a Rossmann-like fold, forming a stable complex with NAD⁺/NADP⁺. Binding of substrate and cofactor can induce global conformational rearrangements, driving the hexamer between “open” and “closed” states and thereby modulating catalytic efficiency.
1.2 Enzymatic Classification
(1) Based on cofactor specificity, GDHs can be divided into NAD⁺-dependent (EC 1.4.1.2), dual-specific (EC 1.4.1.3), and NADP⁺-dependent (EC 1.4.1.4) enzymes. NAD⁺-dependent GDHs are common in animal tissues and some bacteria and are more biased toward oxidative deamination of glutamate, driving flux from glutamate toward α-ketoglutarate and closely coupling to energy metabolism.
(2) NADP⁺-dependent GDHs are more common in plants and some microorganisms and usually favor the reductive amination direction to form glutamate from α-ketoglutarate and ammonia, supporting ammonia assimilation and nitrogen utilization. Dual-specific GDHs can employ both NAD⁺ and NADP⁺; their effective catalytic direction and efficiency depend on the intracellular ratios of these cofactors and on cellular energy and nitrogen status.
1.3 Tissue Distribution and Physiological Localization
(1) In animals, GDH is primarily localized in the mitochondrial matrix, with high abundance in liver, kidney, and brain. Hepatic GDH is a key enzyme for ammonia production from amino acid catabolism and for recycling the carbon skeleton of glutamate. Renal GDH participates in ammonia generation and acid-base balance. In the brain, GDH is involved in the glutamate–glutamine cycle and ammonia buffering, helping to maintain neurotransmitter balance and limit ammonium toxicity.
(2) In microorganisms and plants, GDH is found in the cytosol and/or mitochondria, where it adjusts the dynamic balance between glutamate and α-ketoglutarate and contributes to coordination of carbon and nitrogen metabolism under changing nitrogen availability. GDH expression and activity are finely regulated under different ecological and nutritional conditions, making it a useful entry point for studying nitrogen metabolism regulation.
II. Physiological Functions and Catalytic Mechanism of GDH
2.1 Nitrogen Metabolism and Ammonia Assimilation/Deamination
(1) In microorganisms, GDH is one of the major pathways for ammonia assimilation. At high extracellular ammonia concentrations, α-ketoglutarate reacts with ammonium and NAD(P)H under GDH catalysis to form glutamate. Glutamate then serves as a nitrogen donor for transamination or for glutamine synthesis, supporting biosynthesis of diverse nitrogenous compounds. Compared with the glutamine synthetase/glutamate synthase (GS/GOGAT) system, the GDH route is less energy-intensive and is well-suited for rapid assimilation in high-ammonia environments.
(2) In animals, especially in the liver, GDH more often functions in the oxidative deamination direction. Amino groups from various amino acids are first transferred to glutamate via transaminases; GDH then deaminates glutamate to release free ammonia, which enters the urea cycle for detoxification. At the same time, the carbon skeleton of glutamate is regenerated as α-ketoglutarate and re-enters the TCA cycle, linking nitrogen disposal to energy metabolism.
2.2 Coupling to Energy Metabolism and the TCA Cycle
(1) GDH generates α-ketoglutarate, a key TCA cycle intermediate that can be fully oxidized to provide ATP, reducing equivalents, and biosynthetic precursors. Via this pathway, carbon skeletons of amino acids used as nitrogen donors are efficiently recovered, avoiding waste of carbon resources and helping to maintain an adequate energy supply.
(2) The NADH generated in the oxidative deamination direction can be further oxidized through the mitochondrial respiratory chain to produce ATP. NADPH produced in the reductive amination direction is primarily used in lipid biosynthesis and antioxidant systems. Thus GDH links nitrogen metabolism to the cellular energy and redox state. When energy is limited, cells can upregulate GDH to enhance amino acid catabolism and replenish TCA intermediates and reducing equivalents.
2.3 Catalytic Mechanism and Influencing Factors
(1) The oxidative deamination of glutamate by GDH proceeds via substrate binding, dehydrogenation to form an imine intermediate, hydrolysis to products, and product release. First, glutamate and NAD⁺/NADP⁺ bind sequentially to the active site. With the help of key residues, the α-carbon of glutamate is dehydrogenated, transferring electrons to the cofactor and forming NAD(P)H while generating a Schiff base–type imine intermediate. This intermediate is then hydrolyzed to release α-ketoglutarate and NH₄⁺, and the reduced cofactor dissociates, returning the enzyme to its initial state.
(2) The direction and rate of the reaction depend not only on substrate, product, and cofactor concentrations, but also on cellular energy state and allosteric effectors. Low-energy indicators such as ADP and GDP often act as positive allosteric activators, whereas ATP and GTP act as inhibitors. Certain amino acids (e.g., leucine) can also modulate GDH activity in specific tissues. This makes GDH an important “sensor” that integrates nitrogen metabolism with energy status.
III. Enzymological Properties and Regulatory Features
3.1 Optimal Reaction Conditions
(1) Most GDHs exhibit higher activity under mildly alkaline conditions, with optimal pH typically between 7.8 and 9.0, where key residues in the active site are in favorable ionization states for proton and electron transfer. Optimal temperatures are usually around 30–40 °C; at higher temperatures, partial unfolding and loss of activity occur. Different GDHs show different pH and thermal stabilities. GDHs selected or engineered for industrial use often have enhanced thermostability and broader pH tolerance.
(2) Metal ions, ionic strength, and small metabolites can influence GDH activity. Moderate concentrations of some divalent cations may help maintain structural stability, whereas high concentrations of heavy metals or strong oxidants can trigger inactivation. In practical use, the composition of the buffer and added stabilizers need to be optimized for the target application.
3.2 Cofactor Specificity and Kinetic Parameters
(1) NAD⁺-dependent GDHs usually display higher catalytic efficiency in the oxidative deamination direction and are suitable for tight coupling to the respiratory chain. NADP⁺-dependent GDHs are generally more active in the reductive amination direction and are well-adapted for ammonia assimilation and biosynthesis. Dual-cofactor GDHs differ in Km and Vmax toward NAD⁺ and NADP⁺; cells can fine-tune reaction direction and strength by adjusting the relative levels of these cofactors.
(2) Kinetic parameters such as Km and Vmax characterize GDH affinity for substrates and cofactors and its maximal catalytic capacity, and are useful for comparing different sources or mutants. Protein engineering aimed at lowering Km and increasing catalytic efficiency can yield GDH variants that are more suitable for industrial fermentation or biosensor applications.
3.3 Allosteric Regulation and Integration into Metabolic Networks
(1) GDH is a typical allosteric enzyme. Binding of ADP, GDP, or other low-energy metabolites at regulatory sites promotes a shift of the hexamer to a high-activity conformation, increasing substrate affinity and catalytic rate. Conversely, ATP and GTP stabilize a low-activity conformation and inhibit the reaction. This bidirectional regulation allows GDH to respond dynamically to changes in energy status—accelerating amino acid catabolism when energy is low and limiting ammonia production when energy is sufficient.
(2) In pancreatic β-cells, GDH is also regulated by specific amino acids, such as leucine, which acts as an activator to enhance GDH activity, increase NADH production, and promote ATP generation, thereby contributing to glucose- and amino acid–induced insulin secretion. Such tissue-specific regulation links GDH to endocrine metabolic disorders.
IV. Application Fields of Glutamate Dehydrogenase
4.1 Industrial Fermentation and Amino Acid Production
(1) In industrial fermentation processes for glutamate and related amino acids, GDH is a key enzyme controlling carbon–nitrogen flux. In glutamate fermentation, for example using Corynebacterium glutamicum, GDH catalyzes glutamate formation from α-ketoglutarate and ammonia—this is a central step in glutamate biosynthesis. Overexpressing GDH, optimizing cofactor regeneration, and tailoring nitrogen supply can significantly improve glutamate yield and productivity.
(2) In production routes for other amino acids (such as proline and arginine), adjusting GDH activity to modulate glutamate supply helps balance cell growth and product formation. In metabolic and synthetic biology engineering, GDH is often treated as a “valve” enzyme that merits focused optimization.
4.2 Medical Diagnostics and Clinical Indicators
(1) GDH is mainly localized in hepatic mitochondria. When hepatocytes are severely damaged or undergo necrosis, GDH can leak into the bloodstream, increasing serum GDH activity. Compared with cytosolic enzymes such as ALT and AST, GDH is more indicative of mitochondrial injury and can provide added specificity in certain settings, such as alcoholic liver disease or drug-induced liver injury.
(2) In kidney diseases and disorders associated with hyperammonemia, changes in GDH activity and its metabolic network can also serve as auxiliary research indicators. GDH-based coupled enzymatic kits are widely used for rapid measurement of glutamate, ammonia, and α-ketoglutarate in biological samples, supporting clinical diagnostics and disease monitoring.
4.3 Research Tools and Biotechnological Applications
(1) In metabolic studies, GDH is commonly used as a coupling enzyme, converting glutamate or ammonia changes into variations in NADH/NADPH, which can be monitored at 340 nm or by fluorescence. For example, in ammonia assays, GDH catalyzes the reaction of ammonia with α-ketoglutarate, allowing indirect quantitation of ammonia via cofactor oxidation.
(2) In cancer and neuro-metabolism research, GDH activity and expression, combined with stable isotope tracing, help elucidate the contribution of glutamine/glutamate carbon flux to the TCA cycle. This supports studies on tumor “glutamine addiction,” ammonia buffering in the brain, and metabolic reprogramming in various pathophysiological conditions.
V. GDH and Disease Relevance
5.1 Inherited GDH Dysfunction
Gain-of-function mutations in the GDH-encoding gene (e.g., GLUD1) can increase enzyme activity and reduce sensitivity to allosteric inhibitors, causing β-cells to over-respond to amino acids—especially leucine—resulting in hyperinsulinemic hypoglycemia accompanied by hyperammonemia. Such syndromes highlight the importance of GDH in nutrient sensing and insulin secretion control.
5.2 Liver Disease and Hyperammonemia
During acute or chronic liver injury, mitochondrial damage in hepatocytes can cause GDH release and elevated serum GDH activity, which can be used as an auxiliary marker of mitochondrial damage. Disruption of GDH-related ammonia production and clearance pathways also contributes to ammonia accumulation, increasing the risk of hyperammonemia and hepatic encephalopathy.
5.3 Tumor Metabolism and Potential Targeting
Many tumors are highly dependent on glutamine. Through glutaminase and GDH, the glutamine carbon skeleton is converted to α-ketoglutarate, replenishing TCA intermediates and sustaining rapid proliferation. Upregulated GDH activity is often associated with metabolic reprogramming and enhanced invasiveness. Inhibitors targeting GDH are therefore considered promising candidates for anticancer strategies.
VI. Related Aladdin Products
Catalog No. | Product Name | Product Type | Features/Source | Recommended Application | Remarks |
Glutamate Dehydrogenase (GLDH) | Enzyme/protein | GLDH preparation | Studies of amino acid metabolism, TCA cycle, and nitrogen metabolism; in vitro determination of GLDH activity | Can be used as a standard enzyme for method establishment and control experiments | |
Glutamate Dehydrogenase, Recombinant Microbial | Recombinant enzyme | Recombinant GLDH from microbial source | Microbial metabolic engineering, fermentation engineering, and remodeling of nitrogen metabolic pathways | Suitable for pathway reconstruction and assessing the impact of mutations on enzyme activity | |
Recombinant Glutamate Dehydrogenase (NAD-GDH) | Recombinant enzyme | NAD-dependent GDH | Studies of catalytic mechanism, cofactor preference, and kinetics of NAD-dependent GLDH | Can be compared with NADP-dependent GLDH to analyze differences in cofactor selectivity | |
Glutamate Dehydrogenase (NAD-GDH), Microbial Source | Native enzyme/protein | Microbial NAD-GDH | Studies of microbial nitrogen metabolism regulation, fermentation acid/ammonia production, and carbon–nitrogen balance | Suitable for monitoring metabolic indices in industrial strain screening and process optimization | |
L-Glutamate Dehydrogenase (NADP Type) | Enzyme/protein | L-GLDH, NADP-dependent | Studies of L-glutamate metabolism, NADPH supply, and redox balance | Enables comparison of the respective roles of NAD- vs NADP-dependent GLDH in metabolic pathways | |
R162, Glutamate Dehydrogenase (GDH1) Inhibitor | Small-molecule inhibitor | Small-molecule inhibitor R162 targeting GDH1 | Studies of GDH1 in tumor metabolism, glutamine dependence, and energy metabolism | Suitable for pharmacological and mechanistic studies in combination with GLDH enzymes/cell models | |
Glutamate Dehydrogenase (GDH) Activity Assay Kit (UV micro) | Activity assay kit | UV microplate-based GDH activity assay | Quantitative measurement of GDH activity in cell, tissue, or microbial samples and evaluation of metabolic status | Micro-method with low sample consumption; suitable for multi-sample and high-throughput assays | |
Recombinant L-Glutamate Dehydrogenase (NADP Type) | Recombinant enzyme | Recombinant L-GLDH, NADP-dependent | Planned for studies of L-glutamate metabolism and NADPH-related pathways | Suitable for constructing specific metabolic pathway models, optimizing NADPH supply, and analyzing cofactor preferences |
Glutamate dehydrogenase sits at the crossroads of carbon, nitrogen, and energy metabolism, linking amino acid catabolism, the TCA cycle, and ammonia detoxification. From molecular structure and catalytic mechanism to allosteric regulation and physiological function, GDH exhibits finely tuned regulatory features that allow cells to flexibly adjust amino acid usage and energy supply under different nutritional and energetic states.At the application level, GDH is widely used in enzymatic assays for ammonia and glutamate, in amino acid fermentation and metabolic engineering, and in disease research involving tumor metabolism, inherited metabolic disorders, and hepatic encephalopathy. With advances in structural biology, protein engineering, and systems biology, high-performance GDH variants, precise regulation strategies, and new sensor platforms centered on GDH are expected to continue emerging, offering more options for metabolic disease intervention, green biomanufacturing, and high-performance diagnostic reagent development.
Aladdin: https://www.aladdinsci.com/